Characterization of laser speckle flowgraphy pulse waveform parameters for the evaluation of the optic nerve head and retinal circulation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 03 2021
Historique:
received: 20 12 2020
accepted: 12 03 2021
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 21 10 2021
Statut: epublish

Résumé

To characterize laser speckle flowgraphy (LSFG) pulse waveform parameters for ocular circulation evaluation, a multicenter, prospective, cross-sectional study was conducted in 111 eyes of 86 healthy Japanese individuals. Optic nerve head (ONH) tissue-area, vessel-area mean blur rate (MT and MV, respectively), and MT and MV pulse waveform parameters were obtained using LSFG and ONH structural parameters using planimetry. Multivariate linear mixed-effects modeled regression analysis identified factors contributing to MT- or MV-waveforms using age, gender, smoking history, body mass index, systolic and diastolic blood pressure, heart rate, intraocular pressure, axial length, disc, rim, and β-peripapillary atrophy areas, MT or MV, central retinal artery, and vein equivalents (CRAE and CRVE) as explanatory variables. MT- and MV-waveforms significantly correlated with one or more systemic factors, consistent with previous studies. Following confounding factor adjustment, MT-Skew significantly negatively correlated with β-PPA area (P = 0.026); MT- and MV-flow acceleration index positively correlated with CRAE, MT, and MV (P = 0.041-< 0.001), compatible with these parameters' observed correlations to systemic factors. Significantly negative correlations of the blowout score and acceleration time index to CRAE partly conflicted with their correlations to systemic factors, and other waveform parameters showed little correlation to ocular factors. Thus, Skew and flow acceleration index assisted the in vivo ocular circulation characterization.

Identifiants

pubmed: 33767305
doi: 10.1038/s41598-021-86280-5
pii: 10.1038/s41598-021-86280-5
pmc: PMC7994841
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6847

Références

PLoS One. 2016 Dec 13;11(12):e0168190
pubmed: 27959905
Sci Rep. 2018 Mar 28;8(1):5343
pubmed: 29593269
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4880-90
pubmed: 26225627
Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1195-200
pubmed: 26887825
PLoS One. 2019 Dec 30;14(12):e0227078
pubmed: 31887133
PLoS One. 2018 Feb 27;13(2):e0193023
pubmed: 29486009
Invest Ophthalmol Vis Sci. 1992 May;33(6):2012-8
pubmed: 1582806
Invest Ophthalmol Vis Sci. 2014 Nov 06;55(12):7991-6
pubmed: 25377226
Surv Ophthalmol. 2016 Mar-Apr;61(2):164-86
pubmed: 26498862
Ophthalmology. 2013 Jan;120(1):84-90
pubmed: 23062656
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5417-5425
pubmed: 27756076
Sci Rep. 2017 Oct 24;7(1):13878
pubmed: 29066801
J Mol Cell Cardiol. 1990 Mar;22(3):255-77
pubmed: 21438422
Ophthalmology. 2010 Feb;117(2):282-9
pubmed: 19969361
Am Heart J. 1999 Sep;138(3 Pt 2):220-4
pubmed: 10467216
Am J Ophthalmol. 2010 May;149(5):704-12
pubmed: 20399924
Ophthalmology. 1994 Aug;101(8):1440-4
pubmed: 8058289
Surv Ophthalmol. 2009 Jan-Feb;54(1):74-95
pubmed: 19171211
Exp Eye Res. 2013 Mar;108:10-5
pubmed: 23262066
Ophthalmology. 1996 Nov;103(11):1899-906
pubmed: 8942888
N Engl J Med. 1990 May 31;322(22):1561-6
pubmed: 2139921
Clin Exp Ophthalmol. 2011 Apr;39(3):252-8
pubmed: 20973906
J Cataract Refract Surg. 2015 Nov;41(11):2387-93
pubmed: 26703487
Ophthalmology. 2005 Feb;112(2):245-50
pubmed: 15691558
J Ophthalmol. 2019 Oct 3;2019:1980493
pubmed: 31687195
J Am Coll Cardiol. 1998 Nov;32(5):1454-9
pubmed: 9809962
Transl Vis Sci Technol. 2021 Jan 07;10(1):13
pubmed: 33510952
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7699-706
pubmed: 24130177
Int J Cardiovasc Imaging. 2018 Nov;34(11):1715-1723
pubmed: 29858961
Circulation. 2000 Feb 8;101(5):504-9
pubmed: 10662747
Circulation. 1997 Jul 1;96(1):308-15
pubmed: 9236450
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3110-3118
pubmed: 31323681
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):87-92
pubmed: 20702824
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2285-91
pubmed: 26239310
Invest Ophthalmol Vis Sci. 2014 May 29;55(6):3899-904
pubmed: 24876283
Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1604-11
pubmed: 2745001
Am J Ophthalmol. 2013 Aug;156(2):218-227.e2
pubmed: 23768651
Acta Ophthalmol. 2010 Nov;88(7):723-9
pubmed: 19725814
Curr Eye Res. 2014 Dec;39(12):1207-15
pubmed: 24749668
Ophthalmology. 1996 Dec;103(12):2105-13
pubmed: 9003345
Jpn J Ophthalmol. 2017 May;61(3):223-229
pubmed: 28185066
Graefes Arch Clin Exp Ophthalmol. 1995 Jul;233(7):421-4
pubmed: 7557506
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5397-402
pubmed: 18719076
J Glaucoma. 2018 May;27(5):429-432
pubmed: 29401158
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):396-402
pubmed: 26842757
Ophthalmology. 2010 May;117(5):909-15
pubmed: 20132988
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1858-1864
pubmed: 28358953
Sci Rep. 2019 Nov 29;9(1):17895
pubmed: 31784662
Ophthalmology. 1989 Jan;96(1):16-9
pubmed: 2919047
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):677-684
pubmed: 30786279
Am J Ophthalmol. 2003 Dec;136(6):1022-31
pubmed: 14644212
Ophthalmology. 2008 Jan;115(1):85-93
pubmed: 17629563
Clin Exp Ophthalmol. 2019 Jul;47(5):680-683
pubmed: 30801940
J Atheroscler Thromb. 2012;19(11):999-1005
pubmed: 22786445
Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1275-81
pubmed: 22350058
Jpn J Ophthalmol. 2017 Nov;61(6):441-447
pubmed: 28770355
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):99-105
pubmed: 27743161
PLoS One. 2017 Jul 24;12(7):e0181512
pubmed: 28742142
Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8303-9
pubmed: 23169886
PLoS One. 2016 Feb 12;11(2):e0148812
pubmed: 26872348
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Transl Vis Sci Technol. 2018 Jan 23;7(1):11
pubmed: 29372113
Prog Retin Eye Res. 2002 Jul;21(4):359-93
pubmed: 12150988

Auteurs

Nobuko Enomoto (N)

Department of Ophthalmology, Toho University Ohashi Medical Center, 2-22-36, Ohashi Meguro-ku, Tokyo, 153-8515, Japan. nobuko.enomoto@med.toho-u.ac.jp.

Ayako Anraku (A)

Department of Ophthalmology, Toho University Ohashi Medical Center, 2-22-36, Ohashi Meguro-ku, Tokyo, 153-8515, Japan.

Goji Tomita (G)

Department of Ophthalmology, Toho University Ohashi Medical Center, 2-22-36, Ohashi Meguro-ku, Tokyo, 153-8515, Japan.

Aiko Iwase (A)

Tajimi Iwase Eye Clinic, Tajimi, Gifu, Japan.

Takashi Sato (T)

Department of Ophthalmology, Toho University Ohashi Medical Center, 2-22-36, Ohashi Meguro-ku, Tokyo, 153-8515, Japan.

Nobuyuki Shoji (N)

Department of Ophthalmology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Tomoaki Shiba (T)

Department of Ophthalmology, School of Medicine, Toho University, Tokyo, Japan.

Toru Nakazawa (T)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kazuhisa Sugiyama (K)

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Koji Nitta (K)

Fukui-ken Saiseikai Hospital, Fukui, Japan.

Makoto Araie (M)

Kanto Central Hospital of the Mutual Aid Association of Public School Teachers, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH